Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 May 9;92(9):1800-2.
doi: 10.1038/sj.bjc.6602541.

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

N W J Bulkmans  1 , L Rozendaal, F J Voorhorst, P J F Snijders, C J L M Meijer
Affiliations

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

N W J Bulkmans et al. Br J Cancer. .

Abstract

We prospectively evaluated the 5-year predictive values of adding high-risk human papillomavirus (hrHPV) testing to cytology for the detection of > or = cervical intraepithelial neoplasia (CIN)3 lesions in a population-based cohort of 2810 women. At baseline, nine (0.3%) women had prevalent lesions > or = CIN3, all being hrHPV positive. After 5 years of follow-up, four (6.5%) of the 62 hrHPV-positive women with normal cytology developed lesions > or = CIN3, vs only one (0.05%) of the 2175 hrHPV-negative women with normal cytology. High-risk human papillomavirus testing or combined screening revealed a much higher sensitivity, at the cost of a small decrease in specificity, and a higher negative predictive value for the detection of lesions > or = CIN3 till the next screening round (5 years) than cytology alone.

PubMed Disclaimer

Comment in

References

    1. Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, Weiderpass E (2004) Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 91: 935–941 - PMC - PubMed
    1. Bos AB, van Ballegooijen M, van Oortmarssen GJ, Habbema JD (2002) Women who participate in spontaneous screening are not at higher risk for cervical cancer than women who attend programme screening. Eur J Cancer 38: 827–831 - PubMed
    1. Bulk S, Van Kemenade FJ, Rozendaal L, Meijer CJ (2004) The Dutch CISOE – A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 57: 388–393 - PMC - PubMed
    1. Canfell K, Barnabas R, Patnick J, Beral V (2004) The predicted effect of changes in cervical screening practice in the UK: results from a modelling study. Br J Cancer 91: 530–536 - PMC - PubMed
    1. Clavel C, Cucherousset J, Lorenzato M, Caudroy S, Nou JM, Nazeyrollas P, Polette M, Bory JP, Gabriel R, Quereux C, Birembaut P (2004) Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer 90: 1803–1808 - PMC - PubMed

Publication types